Download PDF
Add Notes
Share ePoster
ePoster URL
ePoster URL
Copy URL
Sorry this feature is only available when you
Sign in
to iPosters.
Save
Cancel
Remove Note
Are you sure you want to continue?
Remove
Cancel
Sorry this feature is only available when you
Sign in
to iPosters.
![[Fam-] trastuzumab deruxtecan (T-DXd; DS-8201a) vs investigator’s choice of treatment in subjects with HER2-positive, unresectable and/or metastatic breast cancer who previously received T-DM1: a randomized, phase 3 trial (DESTINY-Breast02)](https://qa-assets.posterview.com/SABCS/2019/1/Jpg/f/OT1-07-04.jpg)
